These findings were published in August 2025, in Cardiovascular Revascularization Medicine.

Revalesio, a clinical-stage biopharmaceutical company developing treatments for acute and chronic neurological disorders, today announced its participation in the American Society for Experimental ...

Patients with pulmonary adenocarcinoma consulted the neurology department due to multiple initial symptoms of cerebral ischaemia. Examination of each patient revealed pulmonary embolism, the ...

A team of researchers from Skoltech, the Federal Center for Brain and Neurotechnologies (FMBA of Russia), Lomonosov Moscow ...

Wildfire smoke from the Canadian wildfires in 2023 was linked to a higher incidence of severe strokes and increased ...

Highlights in poststroke care from ISC 2026 include benefits of asundexian, promise of an investigational revascularization ...

Ace Therapeutics, a leading provider of preclinical contract research services for stroke drug development, is advancing the discovery and development of novel stroke therapeutics by offering ...

A woman in her 40s presented with progressive cognitive decline, expressive language difficulty and episodic confusion. Her initial symptoms were misattributed to psychiatric illness, and later to ...

Advanced brain imaging is expanding stroke treatment windows, enabling selected patients beyond 24 hours to benefit ...

The clinical syndrome produced by a stroke is determined by the artery or arteries that are occluded. Blood is supplied to the brain by two major sets of arteries, the anterior and posterior ...

Significant progress has been made in acute ischemic stroke care over the past few years, particularly in expanding treatment to patients who were previously considered untreatable. Multiple recent ...

Portable, low-field magnetic resonance imaging (MRI) has the potential to expand access to neuroimaging in environments where conventional MRI is limited. However, diffusion-weighted imaging at low ...